Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents
Ahmed M. Metwaly, Hazem Elkady, Walid E. Elgammal, Ibrahim H. Eissa et autres
0 citationsFigshare
Hazem Elkady
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
129Publications signalées
2996Citations signalées
2Affiliations récentes
Institutions déclarées
Domaines associés
Synthesis and biological activityAngiogenesis and VEGF in CancerBioactive Compounds and Antitumor AgentsComputational Drug Discovery MethodsCancer therapeutics and mechanisms
Publications récentes
Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents
Ahmed M. Metwaly, Hazem Elkady, Walid E. Elgammal, Ibrahim H. Eissa et autres
0 citationsFigshare
Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agents
Ahmed M. Metwaly, Hazem Elkady, Walid E. Elgammal, Ibrahim H. Eissa et autres
0 citationsFuture Medicinal Chemistry
Rational design of a bis-acetanilide hydrazone–thiourea hybrid as a potent VEGFR-2 inhibitor: in silico and in vitro evaluations
Ahmed M. Metwaly, Ibrahim H. Eissa, Walid E. Elgammal, Hazem A. Mahdy et autres
0 citationsChemical Papers
Integrated In Silico and In Vitro Discovery of a VEGFR-2-Targeted Anticancer Benzanilide Lead
Ahmed M. Metwaly, Ibrahim H. Eissa, Walid E. Elgammal, Mohamed Sayed Ramadan et autres
0 citationsJournal of Computational Biophysics and Chemistry
New theobromine-derived EGFR inhibitor: integrated in silico studies and in vitro evaluations
Ahmed M. Metwaly, Hazem Elkady, Reda G. Yousef, Mohammed A. Abdelhamid et autres
0 citationsJournal of Molecular Structure
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activity
Walid E. Elgammal, Hazem Elkady, Aisha A. Alsfouk, Hazem A. Mahdy et autres
0 citationsFigshare
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activity
Walid E. Elgammal, Hazem Elkady, Aisha A. Alsfouk, Hazem A. Mahdy et autres
0 citationsFuture Medicinal Chemistry
Thiazolidin-based dual Aurora kinase inhibitors with potent anticancer activity
Walid E. Elgammal, Hazem Elkady, Aisha A. Alsfouk, Hazem A. Mahdy et autres
0 citationsFigshare
Development of a Novel Benzanilide Derivative Targeting VEGFR-2: Computational Modeling and In Vitro Anticancer Validation
Hazem Elkady, Walid E. Elgammal, Ibrahim H. Eissa, Naeem Hamdy et autres
0 citationsJournal of Computational Biophysics and Chemistry
New N-(isoxazol-3-yl)-4-(1,3,4-thiadiazol-3(2H)-yl)benzenesulfonamide derivatives as potent Aurora kinases inhibitors: Design, synthesis and anti-proliferative activity
Bshra A. Alsfouk, Hazem Elkady, Walid E. Elgammal, A. S. Nofal et autres
0 citationsBioorganic Chemistry
New chromene derivatives as promising VEGFR-2 inhibitors: combined experimental, DFT, and molecular dynamics approaches
Eslam B. Elkaeed, Hazem Elkady, Walid E. Elgammal, Hazem A. Mahdy et autres
1 citationFuture Medicinal Chemistry
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.